Le Lézard
Classified in: Health
Subject: ACC

Nordic Nanovector - Completion of annual general meeting


OSLO, Norway, June 28, 2023 /PRNewswire/ -- Reference is made to the stock exchange announcement made by Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") on 6 June 2023 regarding the Company's acquisition of Thor Medical AS (the "Transaction"), with approval of the Transaction from the Company's annual general meeting (the "AGM") as one of the closing conditions.

Please find attached the minutes from the AGM. All items on the agenda were approved by the AGM, including the agenda items relating to the Transaction.

The Transaction is expected to be consummated on or around 3 July 2023.

About Nordic Nanovector

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.

This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Ludvik Sandnes, Interim CEO & CFO
Cell: +47 907 43 017
Email: [email protected] 

The following files are available for download:

https://mb.cision.com/Main/9819/3796232/2159407.pdf

NANOV - OGF protokoll m_fremmøte - 28. juni 2023(1989561.1)

SOURCE Nordic Nanovector


These press releases may also interest you

at 03:30
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announced the publication of a...

at 03:30
Commit Biologics launches with ?16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease
Commit Biologics ("Commit"), a pioneer in the...

at 03:29
Hugel Achieves Record High Revenue for the First Quarter
Hugel, a global total medical aesthetics company, announced its 1Q24 consolidated financial results on the 9th, reporting revenue of KRW 74.3 billion, operating profit of KRW 24 billion, and net income of KRW...

at 03:00
A major advance on stroke at Montpellier University Hospital published in the New England Journal of Medicine
"LASTE" (LArge Stroke Therapy Evaluation), a prospective, randomized, controlled trial co-led by Professor Vincent Costalat (neuroradiologist, Montpellier, France) and Dr. Caroline Arquizan (vascular neurologist,...

at 03:00
Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of...

at 03:00
Stratosphere Networks Sponsors Anixter Center's Pure Imagination Event
Stratosphere Networks has announced it will sponsor the Anixter Center's annual fundraiser. The Pure Imagination event will take place on Thursday, May 23, from 6 to 9 p.m. at Venue West at 221 N. Paulina St. in Chicago. The Anixter Center provides...

More news about Health...


News published on and distributed by: